Komo Biosciences

Curated by Signal

Provider of next-generation precision genome engineering technology for development and manufacturing of therapeutics

Life Sciences Technologykomobiosciences.com

Overview

Provider of next-generation precision genome engineering technology for development and manufacturing of therapeutics. It offers non-viral, non-nuclease genome engineering platform and site-specific, integrase-mediated cell line development platform for development and manufacturing of biologics, cell and gene therapy, veterinary medicine, AgBio, and SynBio.

Key facts

Founded: 2024
Headquarters: United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Celmatix
Harnessing the power of data and genomics to optimize medical decisions about fertility.
Life Sciences TechnologyNew York City, United States
Empyrean Medical Systems
Developer of AI enabled radiotherapy platform to treat cancer
Life Sciences TechnologyBoca Raton, United States
Lucendi
AI-enabled smart measurement systems using computational microscopy technology for micro-object characterization
Life Sciences TechnologyLos Angeles, United States

About Komo Biosciences

What does Komo Biosciences do?

Provider of next-generation precision genome engineering technology for development and manufacturing of therapeutics.

Where is Komo Biosciences headquartered?

Komo Biosciences is headquartered in United States.

When was Komo Biosciences founded?

Komo Biosciences was founded in 2024.

Which sector is Komo Biosciences in?

Komo Biosciences operates in Life Sciences Technology.

Who are Komo Biosciences's competitors?

Companies similar to Komo Biosciences include Celmatix, Empyrean Medical Systems, and Lucendi.